Impact of Patient Adherence and Test Performance on the Cost-Effectiveness of Cervical Cancer Screening in Developing Countries. The Case of Honduras

Women's Health Issues

Volumn 20, Issue 1, 2010, Pages 35-42

  Perkins, Rebecca B ^a   Langrish, Sarah M ^b   Stern, Linda J ^c   Burgess, James F ^d   Simon, Carol J ^d  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Emma Romero de Callejas Centro de Cancer   (Honduras)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID;

ARTICLE; CANCER INCIDENCE; CANCER SCREENING; COLPOSCOPY; COMPUTER MODEL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FOLLOW UP; HEALTH CARE COST; HONDURAS; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PATIENT REFERRAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WOMEN'S HEALTH;

ACETIC ACID; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; GUIDELINE ADHERENCE; HONDURAS; HUMANS; MASS SCREENING; PATIENT COMPLIANCE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 72749107865     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2009.09.001     Document Type: Article

References (31)

1. Aareleid T., Pukkala E., Thomson H., and Hakama M. Cervical cancer incidence and mortality trends in Finland and Estonia: A screened vs. an unscreened population. European Journal of Cancer 29A (1993) 745-749
2. Agurto I., Sandoval J., De La Rosa M., and Guardado M.E. Improving cervical cancer prevention in a developing country. International Journal for Quality in Health Care 18 (2006) 81-86
3. Arrossi S., Sankaranarayanan R., and Parkin D.M. Incidence and mortality of cervical cancer in Latin America. Salud publica de Mexico 45 Suppl 3 (2003) S306-S314
4. Christopherson W.M. Lucy Wortham James Award. Cytologic detection and diagnosis of cancer. Its contributions and limitations. Cancer 51 (1983) 1201-1208
5. Claeys P., De Vuyst H., Gonzalez C., Garcia A., Bello R.E., and Temmerman M. Performance of the acetic acid test when used in field conditions as a screening test for cervical cancer. Tropical Medicine and International Health 8 (2003) 704-709
6. Denny L. The prevention of cervical cancer in developing countries. British Journal of Obstetrics and Gynaecology 112 (2005) 1204-1212
7. Denny L., Kuhn L., De Souza M., Pollack A.E., Dupree W., and Wright Jr. T.C. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial. Journal of the American Medical Association 294 (2005) 2173-2181
8. Gaffikin L., Blumenthal P.D., Emerson M., and Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project. Lancet 361 (2003) 814-820
9. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahe C., et al. Cost-effectiveness of cervical-cancer screening in five developing countries. New England Journal of Medicine 353 (2005) 2158-2168
10. Goldie S.J., Kuhn L., Denny L., Pollack A., and Wright T.C. Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness. Journal of the American Medical Association 285 (2001) 3107-3115
11. International Agency for Research on Cancer. (2009). [homepage on the Internet]. Available: http://www.iarc.fr/en/about/index.php. Accessed July 28.
12. JHPIEGO. (2009). Regional single visit approach using VIA and cryotherapy clinical training course. Available: http://www.jhpiego.org/media/featarticles/ft20081218.htm. Accessed July 28, 2009.
13. Jeronimo J., Morales O., Horna J., Pariona J., Manrique J., Rubinos J., et al. Visual inspection with acetic acid for cervical cancer screening outside of low-resource settings. Revista panamericana de salud publica 17 (2005) 1-5
14. Laara E., Day N.E., and Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1 (1987) 1247-1249
15. Lazcano-Ponce E.C., Moss S., Alonso de Ruiz P., Salmeron Castro J., and Hernandez Avila M. Cervical cancer screening in developing countries: Why is it ineffective? The case of Mexico. Archives of Medical Research 30 (1999) 240-250
16. Legood R., Gray A.M., Mahe C., Wolstenholme J., Jayant K., Nene B.M., et al. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. International Journal of Cancer 117 (2005) 981-987
17. Mandelblatt J.S., Lawrence W.F., Gaffikin L., Limpahayom K.K., Lumbiganon P., Warakamin S., et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. Journal of the National Cancer Institute 94 (2002) 1469-1483
18. Megevand E., Denny L., Dehaeck K., Soeters R., and Bloch B. Acetic acid visualization of the cervix: An alternative to cytologic screening. Obstetrics and Gynecology 88 (1996) 383-386
19. Melnikow J., Nuovo J., Willan A.R., Chan B.K., and Howell L.P. Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstetrics and Gynecology 92 (1998) 727-735
20. Nuovo J., Melnikow J., Willan A.R., and Chan B.K. Treatment outcomes for squamous intraepithelial lesions. Internation Journal of Gynaecology and Obstetrics 68 (2000) 25-33
21. Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynecologic Pathology 12 (1993) 186-192
22. Perkins R.B., Langrish S.M., Stern L.J., Figueroa J., and Simon C.J. Comparison of visual inspection and Papanicolaou (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?. Tropical Medicine and International Health 12 (2007) 1018-1025
23. Robles S.C., White F., and Peruga A. Trends in cervical cancer mortality in the Americas. Bulletin of the Pan American Health Organ 30 (1996) 290-301
24. Sankaranarayanan R., Basu P., Wesley R.S., Mahe C., Keita N., Mbalawa C.C., et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. International Journal of Cancer 110 (2004) 907-913
25. Secretary of State of Honduras. (2004). Presidential report: Information by department and municipality (appendix 4; pp. 1-37). Honduran State Department, Tegucigalpa, Honduras.
26. Suba E.J., Murphy S.K., Donnelly A.D., Furia L.M., Huynh M.L., and Raab S.S. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. American Journal of Public Health 96 (2006) 480-487
27. U.S. Department of Health And Human Services. Healthy people 2010. Available at (2000), Author, Washington, DC. http://www.healthypeople.gov/document/HTML/Volume1/03Cancer.htm
28. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical-cancer screening: Test qualities in a primary-care setting. Lancet 353 (1999) 869-873
29. World Health Organization. (2009). Comprehensive cervical cancer control, a guide to essential practice. Available: http://www.who.int/reproductive-health/publications/cervical_cancer_gep/text.pdf. Accessed July 28, 2006.
30. Wright Jr. T.C., Massad L.S., Dunton C.J., Spitzer M., Wilkinson E.J., and Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. American Journal of Obstetrics and Gynecology 197 (2007) 346-355
31. Wright Jr. T.C. Cervical cancer screening using visualization techniques. Review. Journal of the National Cancer Institute Monographs 31 (2003) 66-71